Patents by Inventor Stuart D. Shanler

Stuart D. Shanler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Cream Compositions and Methods of Use
    Publication number: 20120149748
    Abstract: The present invention provides pharmaceutical cream compositions comprising oxymetazoline and methods for treating rosacea and other skin disorders as described herein using the above cream compositions.
    Type: Application
    Filed: December 1, 2011
    Publication date: June 14, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Stuart D. Shanler, Christopher Powala, Luis Rios
  • Compositions and methods for treating purpura
    Patent number: 8114898
    Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
    Type: Grant
    Filed: November 17, 2008
    Date of Patent: February 14, 2012
    Assignee: Allergan, Inc.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
    Publication number: 20110034423
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: October 11, 2010
    Publication date: February 10, 2011
    Applicant: VICEPT THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
    Publication number: 20110027201
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: October 11, 2010
    Publication date: February 3, 2011
    Applicant: VICEPT THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using ?-adrenoceptor agonists
    Patent number: 7812049
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: October 12, 2010
    Assignee: Vicept Therapeutics, Inc.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
    Publication number: 20100233109
    Abstract: The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using ?1-adrenergic receptor (?1-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
    Type: Application
    Filed: May 27, 2010
    Publication date: September 16, 2010
    Applicant: VICEPT THERAPEUTICS, INC.
    Inventors: Stuart D. Shanler, Andrew Ondo
  • COMPOSITIONS AND METHODS FOR TREATING PURPURA
    Publication number: 20090130027
    Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
    Type: Application
    Filed: November 17, 2008
    Publication date: May 21, 2009
    Applicant: Aspect Pharmaceuticals LLC
    Inventors: Stuart D. Shanler, Andrew Ondo